Cetera Investment Advisers
IONS icon

Cetera Investment Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Cetera Investment Advisers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,500
Closed -$34.9K – 3800
2024
Q1 		$34.9K Buy
+8,500
New +$405K ﹤0.01% 3601

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cetera Investment Advisers's IONS Position: Q2 2026 in Review

Cetera Investment Advisers increased its Ionis Pharmaceuticals (IONS) stake by 93% in Q2 2026, buying an estimated $792K and bringing the position to 21,808 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

Cetera Investment Advisers first reported a position in IONS in Q2 2020 and has held it in 8 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Cetera Investment Advisers held 21,808 shares of Ionis Pharmaceuticals worth $1.73M as of Q2 2026.
  • Cetera Investment Advisers bought 10,528 Ionis Pharmaceuticals shares in Q2 2026, an estimated $792K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2511 holding.
  • Cetera Investment Advisers first reported a position in Ionis Pharmaceuticals in Q2 2020 and has held it in 8 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.